Healthcare provider profile · identity verified

Dawn Repko

Emergency Medicine · CRESSON, PA · NPI 1710957097

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	708	186
Amlodipine Besylate	Amlodipine Besylate	503	124
Levothyroxine Sodium	Levothyroxine Sodium	444	110
Lisinopril	Lisinopril	420	108
Rosuvastatin Calcium	Rosuvastatin Calcium	377	111
Pantoprazole Sodium	Pantoprazole Sodium	341	89
Losartan Potassium	Losartan Potassium	333	87
Sertraline Hcl	Sertraline Hcl	316	73
Omeprazole	Omeprazole	299	83
Potassium Chloride	Potassium Chloride	290	79
Simvastatin	Simvastatin	281	78
Alprazolam	Alprazolam	260	56
Metformin Hcl	Metformin Hcl	234	61
Gabapentin	Gabapentin	223	64
Metoprolol Succinate	Metoprolol Succinate	205	50
Hydrochlorothiazide	Hydrochlorothiazide	196	50
Furosemide	Furosemide	186	47
Metformin Hcl Er	Metformin Hcl	169	46
Ozempic	Semaglutide	163	27
Famotidine	Famotidine	153	27
Donepezil Hcl	Donepezil Hcl	140	26
Duloxetine Hcl	Duloxetine Hcl	133	27
Lorazepam	Lorazepam	131	39
Synthroid	Levothyroxine Sodium	124	32
Atenolol	Atenolol	122	35
Eliquis	Apixaban	120	31
Trazodone Hcl	Trazodone Hcl	120	26
Tamsulosin Hcl	Tamsulosin Hcl	114	26
Albuterol Sulfate Hfa	Albuterol Sulfate	102	41
Metoprolol Tartrate	Metoprolol Tartrate	101	26
Glimepiride	Glimepiride	97	21
Pravastatin Sodium	Pravastatin Sodium	97	31
Venlafaxine Hcl Er	Venlafaxine Hcl	97	23
Alendronate Sodium	Alendronate Sodium	91	28
Januvia	Sitagliptin Phosphate	89	14
Ezetimibe	Ezetimibe	87	27
Clopidogrel	Clopidogrel Bisulfate	86	20
Fluticasone Propionate	Fluticasone Propionate	77	25
Montelukast Sodium	Montelukast Sodium	77	18
Meloxicam	Meloxicam	74	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	72	22
Oxybutynin Chloride Er	Oxybutynin Chloride	72	18
Memantine Hcl	Memantine Hcl	71	14
Fluoxetine Hcl	Fluoxetine Hcl	70	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	67	15
Olmesartan Medoxomil	Olmesartan Medoxomil	65	17
Escitalopram Oxalate	Escitalopram Oxalate	64	18
Allopurinol	Allopurinol	62	16
Tradjenta	Linagliptin	61	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	58	21
Irbesartan	Irbesartan	52	suppressed
Meclizine Hcl	Meclizine Hcl	51	16
Ropinirole Hcl	Ropinirole Hcl	50	suppressed
Tramadol Hcl	Tramadol Hcl	49	14
Warfarin Sodium	Warfarin Sodium	49	13
Buspirone Hcl	Buspirone Hcl	48	14
Citalopram Hbr	Citalopram Hydrobromide	48	15
Finasteride	Finasteride	48	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	48	17
Amitriptyline Hcl	Amitriptyline Hcl	45	12
Azithromycin	Azithromycin	44	36
Pregabalin	Pregabalin	44	suppressed
Jardiance	Empagliflozin	43	14
Spironolactone	Spironolactone	43	suppressed
Paroxetine Hcl	Paroxetine Hcl	42	12
Zolpidem Tartrate	Zolpidem Tartrate	42	11
Carvedilol	Carvedilol	41	12
Esomeprazole Magnesium	Esomeprazole Magnesium	40	13
Dicyclomine Hcl	Dicyclomine Hcl	38	18
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	38	34
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	37	suppressed
Oxycodone Hcl	Oxycodone Hcl	37	suppressed
Clonazepam	Clonazepam	35	suppressed
Myrbetriq	Mirabegron	35	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	35	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	34	suppressed
Bupropion Hcl Sr	Bupropion Hcl	33	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	33	29
Prednisone	Prednisone	33	31
Terazosin Hcl	Terazosin Hcl	32	suppressed
Bupropion Xl	Bupropion Hcl	31	suppressed
Lansoprazole	Lansoprazole	31	suppressed
Fenofibrate	Fenofibrate,micronized	30	11
Trulicity	Dulaglutide	30	suppressed
Cefdinir	Cefdinir	29	26
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	29	26
Lubiprostone	Lubiprostone	28	suppressed
Tizanidine Hcl	Tizanidine Hcl	28	suppressed
Glipizide Er	Glipizide	27	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Diazepam	Diazepam	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Lovastatin	Lovastatin	24	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	24	suppressed
Azelastine Hcl	Azelastine Hcl	23	suppressed
Baclofen	Baclofen	23	suppressed
Mounjaro	Tirzepatide	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	23	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	22	suppressed
Cephalexin	Cephalexin	21	20
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	18
Nystatin	Nystatin	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	11
Repatha Sureclick	Evolocumab	20	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Ipratropium Bromide	Ipratropium Bromide	18	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	17	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Temazepam	Temazepam	17	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Felodipine Er	Felodipine	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Fluconazole	Fluconazole	15	13
Memantine Hcl Er	Memantine Hcl	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Valsartan	Valsartan	15	suppressed
Celecoxib	Celecoxib	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Cholestyramine	Cholestyramine (With Sugar)	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Nyamyc	Nystatin	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Repaglinide	Repaglinide	11	suppressed
Topiramate	Topiramate	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error